BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 33443384)

  • 1. What Is a Cytokine Storm and Should It Matter to Me?
    Simkin J; Strange T; Leblanc N; Rivera JC
    J Am Acad Orthop Surg; 2021 Apr; 29(7):297-299. PubMed ID: 33443384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
    Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy Between Cytokines and Risk Factors in the Cytokine Storm of COVID-19: Does Ongoing Use of Cytokine Inhibitors Have a Protective Effect?
    Miossec P
    Arthritis Rheumatol; 2020 Dec; 72(12):1963-1966. PubMed ID: 32725790
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm.
    Yang X; You J; Wei Y; Li H; Gao L; Guo Q; Huang Y; Gong C; Yi C
    J Mater Chem B; 2021 Oct; 9(39):8185-8201. PubMed ID: 34528037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation using CONVEHY® for COVID-19: from the storm to the cytokine anticyclone.
    García-Hernández R; Espigares-López MI; Miralles-Aguiar F; Gámiz-Sánchez R; Arroyo Fernández FJ; Pernia Romero A; Torres LM; Calderón Seoane E;
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Feb; 68(2):107-112. PubMed ID: 33455739
    [No Abstract]   [Full Text] [Related]  

  • 10. A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury.
    Westerouen van Meeteren MJ; Van den Heuvel FM; Weijers G; Joosten LA; De Mast Q; Van de Veerdonk FL; Pickkers P; De Nooijer AH; Hoefsloot W; Drenth JP; De Korte CL; Nijveldt R; Netea MG; Tjwa ET
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):166-168. PubMed ID: 33723544
    [No Abstract]   [Full Text] [Related]  

  • 11. Etoposide as Salvage Therapy for Cytokine Storm Due to Coronavirus Disease 2019.
    Patel M; Dominguez E; Sacher D; Desai P; Chandar A; Bromberg M; Caricchio R; Criner GJ;
    Chest; 2021 Jan; 159(1):e7-e11. PubMed ID: 32931823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.
    Panoskaltsis N; McCarthy NE; Stagg AJ; Mummery CJ; Husni M; Arebi N; Greenstein D; Price CL; Al-Hassi HO; Koutinas M; Mantalaris A; Knight SC
    Cancer Immunol Immunother; 2021 Apr; 70(4):1127-1142. PubMed ID: 33033851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
    Leija-Martínez JJ; Huang F; Del-Río-Navarro BE; Sanchéz-Muñoz F; Muñoz-Hernández O; Giacoman-Martínez A; Hall-Mondragon MS; Espinosa-Velazquez D
    Med Hypotheses; 2020 Nov; 144():109935. PubMed ID: 32795834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.
    Shabrish S; Mittra I
    Front Immunol; 2021; 12():622738. PubMed ID: 33597956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Storm.
    Fajgenbaum DC; June CH
    N Engl J Med; 2020 Dec; 383(23):2255-2273. PubMed ID: 33264547
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
    Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
    Front Immunol; 2020; 11():621441. PubMed ID: 33584719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
    Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
    Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.